Key result
Surgical treatment of left-sided prosthetic valve thrombosis resulted in a 20% early hospital mortality rate, with no deaths or recurrences observed during a median follow-up of 29.2 months among survivors.
Observational (n=30)
No
Surgical treatment of left-sided prosthetic valve thrombosis yields excellent long-term outcomes, though early mortality is significantly higher in patients presenting with NYHA class IV symptoms.
Answers are grounded in this paper and cite their sources.
High early mortality in NYHA IV warrants caution for surgery; hypothesis-generating for long-term outcomes in milder cases.
We report a single center experience of surgical treatment of 30 cases of left-sided prosthetic valve thrombosis (PVT). In our series, a diagnosis of PVT was established based on clinical and echocardiographic examinations. Thrombosis was the major etiologic factor in 25 patients (83.3%), while 22 of 25 patients (88%) had a subtherapeutic anticoagulation level. The early hospital mortality rate was 7.1% in patients with New York Heart Association (NYHA) functional classes II - III, and 31.3% in NYHA functional class IV. The median interval from the surgical procedure to follow-up for these patients was 29.2 months. No recurrence or deaths were observed during 3 to 73 months following the surgical procedure.
No takes yet. Share an insight, caveat, or question.
Özkökeli et al. (2005) conducted an observational in Left-sided prosthetic valve thrombosis (n=30). Surgical treatment (valve replacement or thrombectomy) was evaluated on Early hospital mortality. Surgical treatment of left-sided prosthetic valve thrombosis resulted in a 20% early hospital mortality rate, with no deaths or recurrences observed during a median follow-up of 29.2 months among survivors.
Synapse has enriched 10 related papers. Consider them for comparative context: